On March 25, 2025, Canada’s Drug Agency published its annual Watch List, which identifies technologies with the most potential to transform health systems and shape the future of health care in Canada. The 2025 Watch List highlights the top AI technologies and related issues poised to impact health care systems in Canada.
Top five AI technologies:
- AI for notetaking
- AI in clinical training
- AI for disease diagnosis
- AI for disease treatment
- AI for remote monitoring
Top five issues:
- Privacy & data security
- Liability & accountability
- Data availability, quality & bias
- Data sovereignty & governance
- Environmental costs
Should you have any questions, please do not hesitate to contact a member of the Life Sciences Regulatory & Compliance Group.
Related Publications & Articles
-
Canada’s Drug Agency releases new resource and data on drug approval and reimbursement pathway
Canada’s Drug Agency (CDA-AMC) published data on Canada’s drug system as part of the Data Systems and Analytics program.Read More -
Health Canada and U.S. FDA agree to establish information sharing program for generic drug submission reviews
Health Canada and the U.S. Food and Drug Administration (FDA) have created a program to support the establishment of a Request for Information Sharing (RIS) program, which will enhance the exchange of...Read More -
Medical Devices updates: Phase II consultation on Medical Devices Regulations amendments, medical device licences guidance and IMDRF table of contents guidance
On November 17, 2025, Health Canada proposed Phase II amendments to the Medical Devices Regulations (MDR). The first phase of amendments came into force on December 14, 2024 and relate to recalls, mod...Read More
